SMARCA4 and neoplasm: A previous study has demonstrated that inhibition of BRG1 function via the PFI-3 inhibitor, targeting the bromodomain (Fig. 3), increased the radiosensitivity of colon cancer cells in vitro and in a xenograft mouse model resulting in increased tumour cell death following irradiation [97].